These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23088316)

  • 1. Prebiopsy magnetic resonance studies for prostate cancer diagnosis.
    Kumar R; Jagannathan NR
    Int J Urol; 2013 Feb; 20(2):140-1. PubMed ID: 23088316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Magnetic resonance imaging facilitate appropriate treatment selection of prostate cancer patients].
    Boesen L; Thomsen HS
    Ugeskr Laeger; 2013 Jun; 175(23):1634-7. PubMed ID: 23731990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
    Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.
    Schoots IG; Padhani AR
    BJU Int; 2021 Feb; 127(2):175-178. PubMed ID: 33089586
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of Prostate Cancer: Update.
    Verma S
    Top Magn Reson Imaging; 2016 Jun; 25(3):101. PubMed ID: 27187166
    [No Abstract]   [Full Text] [Related]  

  • 8. Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer.
    Kumar V; Jagannathan NR; Thulkar S; Kumar R
    Int J Urol; 2012 Jul; 19(7):602-13. PubMed ID: 22435389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnet Before the Needle Commentary on: MRI-targeted or Standard Biopsy for Prostate-cancer Diagnosis (PRECISION Trial).
    Merrett C; Mannas M; Black PC; Zargar H
    Urology; 2018 Aug; 118():1-2. PubMed ID: 29730255
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
    Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
    AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
    Lawrentschuk N; Fleshner N
    BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.
    Park BK; Park JW; Park SY; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
    AJR Am J Roentgenol; 2011 Nov; 197(5):W876-81. PubMed ID: 22021535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate tumors].
    Devonec M
    Rev Prat; 2002 Jan; 52(2):207-12. PubMed ID: 11915568
    [No Abstract]   [Full Text] [Related]  

  • 15. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer Diagnosis Using MR/Ultrasound-Fusion Guided Biopsy: Ending the "Needle in a Haystack" Conundrum?
    Tombal BF; Van Nieuwenhove S; Lecouvet FE
    JAMA Oncol; 2015 Sep; 1(6):831-2. PubMed ID: 26181913
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of MRI in prostate cancer diagnosis and management.
    Mendhiratta N; Taneja SS; Rosenkrantz AB
    Future Oncol; 2016 Nov; 12(21):2431-2443. PubMed ID: 27641839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?
    Schwartz LH; Basch E
    JAMA; 2015 Jan; 313(4):367-8. PubMed ID: 25626034
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging-guided biopsy detects prostate cancer.
    Printz C
    Cancer; 2013 May; 119(10):1767. PubMed ID: 23649489
    [No Abstract]   [Full Text] [Related]  

  • 20. The emerging role of magnetic resonance imaging in the diagnosis and management of prostate cancer.
    Barocas DA
    Urol Oncol; 2016 Jul; 34(7):294-5. PubMed ID: 27289426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.